Selecta Biosciences Inc (SELB)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Werner Cautreels
Employees:
39
480 ARSENAL WAY, WATERTOWN, MA 02472
617-923-1400

Selecta Biosciences, Inc. is a clinical stage biopharmaceutical company. The company engages in the design of immunotherapies and vaccines that modulate immune responses to treat and prevent disease. It focuses on the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company was founded by Robert S. Langer Jr., Omid C. Farokhzad and Ulrich von Andrian in 2007 and is headquartered in Watertown, MA.

Data derived from most recent annual or quarterly report
Market Cap 166.547 Million Shares Outstanding124.289 Million Avg 30-day Volume 3.361 Million
P/E Ratio5.6673 Dividend Yield0.0 EPS-0.18
Price to Revenue1.4526 Debt to Equity0.4616 EBITDA12.471 Million
Price to Book Value2.8139 Operating Margin12.3433 Enterprise Value63.219 Million
Current Ratio3.313 EPS Growth1.116 Quick Ratio3.175
1 Yr BETA 1.4437 52-week High/Low 4.7 / 0.65 Profit Margin25.6309
Operating Cash Flow Growth-274.5137 Altman Z-Score-1.0727 Free Cash Flow to Firm -91.106 Million
Earnings Report2022-08-04
View SEC Filings from SELB instead.

View recent insider trading info

Funds Holding SELB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SELB BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-06-22:
    Item 8.01: Other Events
  • 8-K: filed on 2022-06-21:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-17:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-06-13:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-03:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2022-05-18:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-13:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-07:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-06:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    180 Thousand total shares from 2 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    10.9 Thousand total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    COX CARRIE SMITH

    • Director
    212,881 2022-06-13 3

    BRUNN CARSTEN PRESIDENT AND CEO

    • Officer
    • Director
    556,265 2022-06-01 11

    BARABE TIMOTHY C

    • Director
    250,013 2022-05-09 4

    SPRINGER TIMOTHY A

    • Director
    • 10% Owner
    42,259,733 2022-04-11 4

    TRABER PETER G CHIEF MEDICAL OFFICER

    • Officer
    251,355 2022-01-05 7

    JOHNSTON LLOYD P. CHIEF OPERATIONS OFFICER

    • Officer
    175,299 2022-01-05 6

    KISHIMOTO TAKASHI KEI CHIEF SCIENTIFIC OFFICER

    • Officer
    268,353 2022-01-05 6

    ANDO GORAN

    • Director
    40,000 2022-01-03 1

    ZENNER PATRICK J

    • Director
    40,000 2022-01-03 1

    MYERS SCOTT DUNSETH

    • Director
    40,000 2022-01-03 1

    DESILVA NISHAN M

    • Director
    40,000 2022-01-03 2

    SALLIN AYMERIC

    • Director
    40,000 2022-01-03 1

    TAN KEVIN CHIEF FINANCIAL OFFICER

    • Officer
    417,000 2022-01-03 4

    DONOHUE ANN K. VP FINANCE

    • Officer
    4,187 2021-05-27 0

    DAHMS BRADFORD D. CHIEF FINANCIAL OFFICER

    • Officer
    38,000 2021-01-04 0

    KOGAN ELONA ESQ. GENERAL COUNSEL

    • Officer
    0 2020-01-02 0

    SMOLINSKI STEPHEN CHIEF COMMERCIAL OFFICER

    • Officer
    0 2020-01-02 0

    SCHECTER ALISON D. CHIEF MEDICAL OFFICER

    • Officer
    0 2020-01-02 0

    NASHAT AMIR

    • Director
    0 2019-06-14 0

    FAROKHZAD OMID

    • Director
    0 2019-06-14 0

    HUTT PETER BARTON

    • Director
    0 2018-06-15 0

    LEAMAN JOHN HAROLD CFO, TREAS. & HD CORP STRATEGY

    • Officer
    0 2018-06-15 0

    ABRAHAM DAVID GC, CCO & CORPORATE SECRETARY

    • Officer
    0 2018-06-15 0

    SANDS EARL CHIEF MEDICAL OFFICER

    • Officer
    7,500 2017-11-17 0

    CAUTREELS WERNER PRESIDENT AND CEO

    • Officer
    • Director
    321,203 2017-11-13 0

    SIEWERS DAVID CFO AND TREASURER

    • Officer
    0 2017-09-20 0

    KELLER PETER CHIEF BUSINESS OFFICER

    • Officer
    0 2017-07-07 0

    KANIA EDWIN M JR

    • Director
    586,595 2017-05-16 0

    TAS PARTNERS, LLC

    LEUKON INVESTMENTS, LP

    SPRINGER TIMOTHY A

    • Director
    1,682,604 2016-06-27 0

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP III LLC

    ISALY SAMUEL D

    • Director
    • 10% Owner
    1,842,797 2016-06-27 0

    FLAGSHIP VENTURES FUND 2007, L.P.

    FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

    AFEYAN NOUBAR

    • 10% Owner
    No longer subject to file 2016-06-27 0

    GORDON CARL L

    • Director
    • 10% Owner
    1,842,797 2016-06-27 0

    POLARIS VENTURE MANAGEMENT CO. V, L.L.C.

    POLARIS VENTURE PARTNERS V, L.P.

    POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.

    POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.

    POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.

    • 10% Owner
    1,903,437 2016-06-27 0

    RUSNANO

    • 10% Owner
    No longer subject to file 2016-06-27 0

    OSAGE UNIVERSITY PARTNERS II, L.P.

    OSAGE UNIVERSITY GP II, L.P.

    OSAGE PARTNERS, LLC

    • 10% Owner
    No longer subject to file 2016-06-27 0

    NANODIMENSION MANAGEMENT LTD

    NANODIMENSION LIMITED PARTNERSHIP

    • 10% Owner
    No longer subject to file 2016-06-27 0

    VTB CAPITAL I2BF NETHERLANDS, B.V.

    SELECTA RKFN, LTD.

    • 10% Owner
    No longer subject to file 2016-06-27 0

    FLAGSHIP VENTURES FUND 2007, L.P.

    FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

    AFEYAN NOUBAR

    KANIA EDWIN M JR

    • Director
    • 10% Owner
    31,115 2016-06-21 0

    LANGER ROBERT

    • 10% Owner
    457,603 2016-06-21 0

    SHAYDULLINA LEYSAN

    • Director
    0 2016-06-21 0

    VON ANDRIAN ULRICH

    • 10% Owner
    515,494 2016-06-21 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    COX CARRIE SMITH - Director

    2022-06-15 16:16:11 -0400 2022-06-13 P 130,000 $1.15 a 212,881 direct -7.4627 -0.7463 4.4776 5 -7.4627 2

    BRUNN CARSTEN - Director - Officer PRESIDENT AND CEO

    2022-06-03 16:44:19 -0400 2022-06-01 M 10,938 a 534,390 direct 17.2345 12.2244 25.2505 3 0.0 1

    BRUNN CARSTEN - Director - Officer PRESIDENT AND CEO

    2022-06-03 16:44:19 -0400 2022-06-01 M 10,938 d 21,875 direct

    BARABE TIMOTHY C - Director

    2022-05-11 16:21:42 -0400 2022-05-09 P 50,000 $0.77 a 250,013 direct 5.1873 11.5274 93.0836 101.7291 29 -0.4323 9

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    SELECTA BIOSCIENCES INC SELB 2022-06-28 22:15:04 UTC 0.8361 0.7339 700000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 21:45:03 UTC 0.8325 0.7375 700000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 21:15:03 UTC 0.8325 0.7375 700000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 20:45:03 UTC 0.8325 0.7375 700000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 20:15:04 UTC 0.8325 0.7375 700000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 19:45:03 UTC 0.8325 0.7375 700000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 19:15:03 UTC 0.8325 0.7375 700000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 18:45:03 UTC 0.8339 0.7361 700000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 18:15:04 UTC 0.8339 0.7361 700000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 17:45:03 UTC 0.8339 0.7361 700000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 17:15:03 UTC 0.8339 0.7361 700000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 16:45:06 UTC 0.7535 0.8165 700000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 16:15:03 UTC 0.7535 0.8165 700000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 15:45:03 UTC 0.7535 0.8165 700000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 15:15:03 UTC 0.7535 0.8165 700000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 14:45:03 UTC 0.7535 0.8165 450000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 14:15:04 UTC 0.7535 0.8165 450000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 13:45:03 UTC 0.732 0.838 450000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 13:15:03 UTC 0.732 0.838 400000
    SELECTA BIOSCIENCES INC SELB 2022-06-28 12:45:03 UTC 0.732 0.838 350000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments